Access Bio Decides to Issue Convertible Bonds Worth 11.1 Billion KRW

[Asia Economy Reporter Minji Lee] Access Bio announced on the 16th that it has decided to issue the 4th series of registered, non-interest-bearing private convertible bonds worth 11.132 billion KRW to raise facility funds and operating capital. The coupon rate and maturity interest rate are 0% and 2%, respectively.

The designated subscriber is Ginkgo Bioworks, Inc. The company explained, "We decided to issue convertible bonds to purchase and install production facilities to expand RDT production capacity and to secure operating expenses."

The issuance region is the United States. The reference exchange rate was set at 1,132.2 KRW.

This content was produced with the assistance of AI translation services.